Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1 clinical trials · Condition
◉ Watch Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
| Record | Firm | Date |
|---|---|---|
| Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer (NCT04869371) | Hongqian Guo | 2018-12-12 |
Track Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel automatically
Every clearance here is in the API, with alerts when new ones post.